跳转至内容
Merck
  • Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves.

Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves.

PloS one (2014-10-14)
Nikki A McLean, Bogdan F Popescu, Tessa Gordon, Douglas W Zochodne, Valerie M K Verge
摘要

Rapid and efficient axon remyelination aids in restoring strong electrochemical communication with end organs and in preventing axonal degeneration often observed in demyelinating neuropathies. The signals from axons that can trigger more effective remyelination in vivo are still being elucidated. Here we report the remarkable effect of delayed brief electrical nerve stimulation (ES; 1 hour @ 20 Hz 5 days post-demyelination) on ensuing reparative events in a focally demyelinated adult rat peripheral nerve. ES impacted many parameters underlying successful remyelination. It effected increased neurofilament expression and phosphorylation, both implicated in axon protection. ES increased expression of myelin basic protein (MBP) and promoted node of Ranvier re-organization, both of which coincided with the early reappearance of remyelinated axons, effects not observed at the same time points in non-stimulated demyelinated nerves. The improved ES-associated remyelination was accompanied by enhanced clearance of ED-1 positive macrophages and attenuation of glial fibrillary acidic protein expression in accompanying Schwann cells, suggesting a more rapid clearance of myelin debris and return of Schwann cells to a nonreactive myelinating state. These benefits of ES correlated with increased levels of brain derived neurotrophic factor (BDNF) in the acute demyelination zone, a key molecule in the initiation of the myelination program. In conclusion, the tremendous impact of delayed brief nerve stimulation on enhancement of the innate capacity of a focally demyelinated nerve to successfully remyelinate identifies manipulation of this axis as a novel therapeutic target for demyelinating pathologies.

材料
货号
品牌
产品描述

Sigma-Aldrich
甘油, ACS reagent, ≥99.5%
Sigma-Aldrich
甘油, for molecular biology, ≥99.0%
Sigma-Aldrich
甘油, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
邻二甲苯, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
邻二甲苯, reagent grade, ≥98.0%
Sigma-Aldrich
甘油 溶液, 83.5-89.5% (T)
Sigma-Aldrich
甘油, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
甘油, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
甘油, puriss., anhydrous, 99.0-101.0% (alkalimetric)
USP
甘油, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甘油, FCC, FG
Sigma-Aldrich
甘油, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Supelco
邻二甲苯, suitable for HPLC, 98%
Sigma-Aldrich
甘油, ≥99.5%
Sigma-Aldrich
甘油, BioXtra, ≥99% (GC)
Supelco
甘油, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
邻二甲苯, anhydrous, 97%
Sigma-Aldrich
甘油, meets USP testing specifications
Sigma-Aldrich
甘油 溶液, puriss., meets analytical specification of Ph. Eur., BP, 84-88%
Supelco
邻二甲苯, analytical standard
Supelco
甘油, analytical standard
Sigma-Aldrich
甘油, Vetec, reagent grade, 99%
Sigma-Aldrich
甘油, tested according to Ph. Eur., anhydrous
Supelco
邻二甲苯, Pharmaceutical Secondary Standard; Certified Reference Material